Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy
CONCLUSION: Most patients successfully received IORT as a tumor bed boost after neoadjuvant chemotherapy. Thus, IORT may be a safe and feasible option for patients with advanced-stage breast cancer receiving neoadjuvant chemotherapy.PMID:38373832 | PMC:PMC10896667 | DOI:10.3349/ymj.2023.0229 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - February 19, 2024 Category: Universities & Medical Training Authors: Gowoon Yang Jun Won Kim Ik Jae Lee Joon Jeong Sung Gwe Ahn Soong June Bae Jee Hung Kim Yeona Cho Source Type: research

Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy
CONCLUSION: Most patients successfully received IORT as a tumor bed boost after neoadjuvant chemotherapy. Thus, IORT may be a safe and feasible option for patients with advanced-stage breast cancer receiving neoadjuvant chemotherapy.PMID:38373832 | PMC:PMC10896667 | DOI:10.3349/ymj.2023.0229 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - February 19, 2024 Category: Universities & Medical Training Authors: Gowoon Yang Jun Won Kim Ik Jae Lee Joon Jeong Sung Gwe Ahn Soong June Bae Jee Hung Kim Yeona Cho Source Type: research

Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy
CONCLUSION: Most patients successfully received IORT as a tumor bed boost after neoadjuvant chemotherapy. Thus, IORT may be a safe and feasible option for patients with advanced-stage breast cancer receiving neoadjuvant chemotherapy.PMID:38373832 | PMC:PMC10896667 | DOI:10.3349/ymj.2023.0229 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - February 19, 2024 Category: Universities & Medical Training Authors: Gowoon Yang Jun Won Kim Ik Jae Lee Joon Jeong Sung Gwe Ahn Soong June Bae Jee Hung Kim Yeona Cho Source Type: research

Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy
CONCLUSION: Most patients successfully received IORT as a tumor bed boost after neoadjuvant chemotherapy. Thus, IORT may be a safe and feasible option for patients with advanced-stage breast cancer receiving neoadjuvant chemotherapy.PMID:38373832 | PMC:PMC10896667 | DOI:10.3349/ymj.2023.0229 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - February 19, 2024 Category: Universities & Medical Training Authors: Gowoon Yang Jun Won Kim Ik Jae Lee Joon Jeong Sung Gwe Ahn Soong June Bae Jee Hung Kim Yeona Cho Source Type: research

Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy
CONCLUSION: Most patients successfully received IORT as a tumor bed boost after neoadjuvant chemotherapy. Thus, IORT may be a safe and feasible option for patients with advanced-stage breast cancer receiving neoadjuvant chemotherapy.PMID:38373832 | PMC:PMC10896667 | DOI:10.3349/ymj.2023.0229 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - February 19, 2024 Category: Universities & Medical Training Authors: Gowoon Yang Jun Won Kim Ik Jae Lee Joon Jeong Sung Gwe Ahn Soong June Bae Jee Hung Kim Yeona Cho Source Type: research

Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy
CONCLUSION: Most patients successfully received IORT as a tumor bed boost after neoadjuvant chemotherapy. Thus, IORT may be a safe and feasible option for patients with advanced-stage breast cancer receiving neoadjuvant chemotherapy.PMID:38373832 | PMC:PMC10896667 | DOI:10.3349/ymj.2023.0229 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - February 19, 2024 Category: Universities & Medical Training Authors: Gowoon Yang Jun Won Kim Ik Jae Lee Joon Jeong Sung Gwe Ahn Soong June Bae Jee Hung Kim Yeona Cho Source Type: research

Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy
CONCLUSION: Most patients successfully received IORT as a tumor bed boost after neoadjuvant chemotherapy. Thus, IORT may be a safe and feasible option for patients with advanced-stage breast cancer receiving neoadjuvant chemotherapy.PMID:38373832 | PMC:PMC10896667 | DOI:10.3349/ymj.2023.0229 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - February 19, 2024 Category: Universities & Medical Training Authors: Gowoon Yang Jun Won Kim Ik Jae Lee Joon Jeong Sung Gwe Ahn Soong June Bae Jee Hung Kim Yeona Cho Source Type: research

Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy
CONCLUSION: Most patients successfully received IORT as a tumor bed boost after neoadjuvant chemotherapy. Thus, IORT may be a safe and feasible option for patients with advanced-stage breast cancer receiving neoadjuvant chemotherapy.PMID:38373832 | PMC:PMC10896667 | DOI:10.3349/ymj.2023.0229 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - February 19, 2024 Category: Universities & Medical Training Authors: Gowoon Yang Jun Won Kim Ik Jae Lee Joon Jeong Sung Gwe Ahn Soong June Bae Jee Hung Kim Yeona Cho Source Type: research

Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy
CONCLUSION: Most patients successfully received IORT as a tumor bed boost after neoadjuvant chemotherapy. Thus, IORT may be a safe and feasible option for patients with advanced-stage breast cancer receiving neoadjuvant chemotherapy.PMID:38373832 | PMC:PMC10896667 | DOI:10.3349/ymj.2023.0229 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - February 19, 2024 Category: Universities & Medical Training Authors: Gowoon Yang Jun Won Kim Ik Jae Lee Joon Jeong Sung Gwe Ahn Soong June Bae Jee Hung Kim Yeona Cho Source Type: research

Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy
CONCLUSION: Most patients successfully received IORT as a tumor bed boost after neoadjuvant chemotherapy. Thus, IORT may be a safe and feasible option for patients with advanced-stage breast cancer receiving neoadjuvant chemotherapy.PMID:38373832 | PMC:PMC10896667 | DOI:10.3349/ymj.2023.0229 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - February 19, 2024 Category: Universities & Medical Training Authors: Gowoon Yang Jun Won Kim Ik Jae Lee Joon Jeong Sung Gwe Ahn Soong June Bae Jee Hung Kim Yeona Cho Source Type: research

Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy
CONCLUSION: Most patients successfully received IORT as a tumor bed boost after neoadjuvant chemotherapy. Thus, IORT may be a safe and feasible option for patients with advanced-stage breast cancer receiving neoadjuvant chemotherapy.PMID:38373832 | PMC:PMC10896667 | DOI:10.3349/ymj.2023.0229 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - February 19, 2024 Category: Universities & Medical Training Authors: Gowoon Yang Jun Won Kim Ik Jae Lee Joon Jeong Sung Gwe Ahn Soong June Bae Jee Hung Kim Yeona Cho Source Type: research

Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy
CONCLUSION: Most patients successfully received IORT as a tumor bed boost after neoadjuvant chemotherapy. Thus, IORT may be a safe and feasible option for patients with advanced-stage breast cancer receiving neoadjuvant chemotherapy.PMID:38373832 | PMC:PMC10896667 | DOI:10.3349/ymj.2023.0229 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - February 19, 2024 Category: Universities & Medical Training Authors: Gowoon Yang Jun Won Kim Ik Jae Lee Joon Jeong Sung Gwe Ahn Soong June Bae Jee Hung Kim Yeona Cho Source Type: research

Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy
CONCLUSION: Most patients successfully received IORT as a tumor bed boost after neoadjuvant chemotherapy. Thus, IORT may be a safe and feasible option for patients with advanced-stage breast cancer receiving neoadjuvant chemotherapy.PMID:38373832 | PMC:PMC10896667 | DOI:10.3349/ymj.2023.0229 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - February 19, 2024 Category: Universities & Medical Training Authors: Gowoon Yang Jun Won Kim Ik Jae Lee Joon Jeong Sung Gwe Ahn Soong June Bae Jee Hung Kim Yeona Cho Source Type: research

Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy
CONCLUSION: Most patients successfully received IORT as a tumor bed boost after neoadjuvant chemotherapy. Thus, IORT may be a safe and feasible option for patients with advanced-stage breast cancer receiving neoadjuvant chemotherapy.PMID:38373832 | PMC:PMC10896667 | DOI:10.3349/ymj.2023.0229 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - February 19, 2024 Category: Universities & Medical Training Authors: Gowoon Yang Jun Won Kim Ik Jae Lee Joon Jeong Sung Gwe Ahn Soong June Bae Jee Hung Kim Yeona Cho Source Type: research

Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy
CONCLUSION: Most patients successfully received IORT as a tumor bed boost after neoadjuvant chemotherapy. Thus, IORT may be a safe and feasible option for patients with advanced-stage breast cancer receiving neoadjuvant chemotherapy.PMID:38373832 | PMC:PMC10896667 | DOI:10.3349/ymj.2023.0229 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - February 19, 2024 Category: Universities & Medical Training Authors: Gowoon Yang Jun Won Kim Ik Jae Lee Joon Jeong Sung Gwe Ahn Soong June Bae Jee Hung Kim Yeona Cho Source Type: research